Report Categories
View AllRecent Articles
View All
Erii Stock Analysis Energy Recovery Inc Slight Dip At 10.2 Usd Near Term Outlook 20260403 1
Is Icahn IEP stock stable under market conditions In Focus 20260420
Hyperscale Data GPUS Stock Initiates Position Investor Concern 20260420
HPP Hudson posts far wider Q4 2025 loss than estimates yet shares climb on favorable investor sentiment
Is GRI Bio GRI stock hiding in plain sight 178 20260511
Middle East ConflictDriven Supply Chain Disruptions Inflation and Output Risks for Global Consumer Goods Sectors
The debt management strategy at Boyd Group BGSI Q4 2025 Earnings Beat Estimates
Ross Stores Inc ROST Poised for Market Share Gains Amid SectorWide Marketing Cost Inflation
SPWR SunPower Q2 2025 EPS falls far short of estimates shares dip 045 amid rising profitability concerns
CHKP Check Point posts 206 percent Q4 2025 EPS beat shares register 064 percent gain in todays trading
Digi Power X DGXX Climbs 1011 Resistance at 835 in Focus 20260515
Orkla India Reports 75 PAT Growth in Q4 FY26 as Digital Commerce Surges
Omnicom Group OMC Holds 7140 Direction Awaited 20260515
Aus Oilseeds COOT Down 166 How Low Could It Go 20260515
Vietnam Solar Startup Secures 15 Million in Funding Amid IranLinked Energy Market Volatility
FGBIP Q1 2026 Earnings Preferred Stock EPS Surges Past Estimates as Company Shows Strong Profitability
Europes Satellite and AI Dependency Risks National Security Warns Telecom CEO
AI Rally Drives European Stocks to TripleDigit Gains This Year
OTEX Q1 2026 Earnings EPS Beats Estimates by 746 Shares Edge Higher
KEP Q4 2025 Earnings EPS Miss Weighs on Shares Amid Cost Pressures
FULTP Q1 2026 Earnings Preferred Dividend Beat Supports Stable Income Profile
WVE Q1 2026 Earnings EPS Beat with 607 Surprise Shares Dip
enGene Holdings ENGN Q1 2026 Earnings Narrower Loss Than Expected Despite No Revenue
Garmin Ltd GRMN Holds Near Resistance After Modest Gains
BiomX Inc PHGE Slides 7 Crucial Support Test Nears as Selling Pressure Intensifies
Strata Critical Medical SRTA Surges 57 as Buyers Defend 582 Support Level
Axsome Therapeutics AXSM Holds Steady Near Resistance as Bullish Momentum Continues